153 related articles for article (PubMed ID: 38783680)
1. Guidelines for Manufacturing and Application of Organoids: Skin.
Lee S; Rim YA; Kim J; Lee SH; Park HJ; Kim H; Ahn SJ; Ju JH
Int J Stem Cells; 2024 May; 17(2):182-193. PubMed ID: 38783680
[TBL] [Abstract][Full Text] [Related]
2. Guidelines for Manufacturing and Application of Organoids: Heart.
Lee HA; Woo DH; Lim DS; Oh J; Kim CY; Bae ON; Ahn SJ
Int J Stem Cells; 2024 May; 17(2):130-140. PubMed ID: 38777829
[TBL] [Abstract][Full Text] [Related]
3. Essential Guidelines for Manufacturing and Application of Organoids.
Ahn SJ; Lee S; Kwon D; Oh S; Park C; Jeon S; Lee JH; Kim TS; Oh IU
Int J Stem Cells; 2024 May; 17(2):102-112. PubMed ID: 38764240
[TBL] [Abstract][Full Text] [Related]
4. Guidelines for Manufacturing and Application of Organoids: Liver.
Moon HR; Mun SJ; Kim TH; Kim H; Kang D; Kim S; Shin JH; Choi D; Ahn SJ; Son MJ
Int J Stem Cells; 2024 May; 17(2):120-129. PubMed ID: 38773747
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a tiered in vitro testing strategy for assessing the ocular and dermal irritation/corrosion potential of pharmaceutical compounds for worker safety.
Graham JC; Wilt N; Costin GE; Villano C; Bader J; Krawiec L; Sly E; Gould J
Cutan Ocul Toxicol; 2018 Dec; 37(4):380-390. PubMed ID: 30035615
[TBL] [Abstract][Full Text] [Related]
6. Guidelines for Manufacturing and Application of Organoids: Lung.
Lim K; Lee MO; Choi J; Kim JH; Kim EM; Woo CG; Chung C; Cho YH; Hong SH; Cho YJ; Ahn SJ
Int J Stem Cells; 2024 May; 17(2):147-157. PubMed ID: 38777828
[TBL] [Abstract][Full Text] [Related]
7. Guidelines for Manufacturing and Application of Organoids: Kidney.
Kang HM; Kim DS; Kim YK; Shin K; Ahn SJ; Jung CR
Int J Stem Cells; 2024 May; 17(2):141-146. PubMed ID: 38764433
[TBL] [Abstract][Full Text] [Related]
8. Human-Derived In Vitro Models Used for Skin Toxicity Testing Under REACh.
Kolle SN; Landsiedel R
Handb Exp Pharmacol; 2021; 265():3-27. PubMed ID: 33136188
[TBL] [Abstract][Full Text] [Related]
9. Alternative in vitro models used in the main safety tests of cosmetic products and new challenges.
Filaire E; Nachat-Kappes R; Laporte C; Harmand MF; Simon M; Poinsot C
Int J Cosmet Sci; 2022 Dec; 44(6):604-613. PubMed ID: 35842748
[TBL] [Abstract][Full Text] [Related]
10. Towards manufacturing of human organoids.
Ashok A; Choudhury D; Fang Y; Hunziker W
Biotechnol Adv; 2020; 39():107460. PubMed ID: 31626951
[TBL] [Abstract][Full Text] [Related]
11.
Eberlin S; Facchini G; da Silva GH; Eberlin S; Bragatto AR; Pinheiro ALTA; da Silva Pinheiro A
Altern Lab Anim; 2021 Jul; 49(4):137-146. PubMed ID: 34399588
[TBL] [Abstract][Full Text] [Related]
12. Validation of Alternative In Vitro Methods to Animal Testing: Concepts, Challenges, Processes and Tools.
Griesinger C; Desprez B; Coecke S; Casey W; Zuang V
Adv Exp Med Biol; 2016; 856():65-132. PubMed ID: 27671720
[TBL] [Abstract][Full Text] [Related]
13. Safety assessment of a novel active ingredient, acetyl aspartic acid, according to the EU Cosmetics Regulation and the Scientific Committee on Consumer Safety guidelines.
Daly P; Moran G
Int J Cosmet Sci; 2015 Oct; 37 Suppl 1():21-7. PubMed ID: 26114401
[TBL] [Abstract][Full Text] [Related]
14. A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: skin irritation.
Macfarlane M; Jones P; Goebel C; Dufour E; Rowland J; Araki D; Costabel-Farkas M; Hewitt NJ; Hibatallah J; Kirst A; McNamee P; Schellauf F; Scheel J
Regul Toxicol Pharmacol; 2009 Jul; 54(2):188-96. PubMed ID: 19393278
[TBL] [Abstract][Full Text] [Related]
15. Testing strategies in mutagenicity and genetic toxicology: an appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes.
Kirkland DJ; Henderson L; Marzin D; Müller L; Parry JM; Speit G; Tweats DJ; Williams GM
Mutat Res; 2005 Dec; 588(2):88-105. PubMed ID: 16326131
[TBL] [Abstract][Full Text] [Related]
16. Amended final report on the safety assessment of glyceryl dilaurate, glyceryl diarachidate, glyceryl dibehenate, glyceryl dierucate, glyceryl dihydroxystearate, glyceryl diisopalmitate, glyceryl diisostearate, glyceryl dilinoleate, glyceryl dimyristate, glyceryl dioleate, glyceryl diricinoleate, glyceryl dipalmitate, glyceryl dipalmitoleate, glyceryl distearate, glyceryl palmitate lactate, glyceryl stearate citrate, glyceryl stearate lactate, and glyceryl stearate succinate.
Int J Toxicol; 2007; 26 Suppl 3():1-30. PubMed ID: 18273450
[TBL] [Abstract][Full Text] [Related]
17. Organoids: Construction and Application in Gastric Cancer.
Huo C; Zhang X; Gu Y; Wang D; Zhang S; Liu T; Li Y; He W
Biomolecules; 2023 May; 13(5):. PubMed ID: 37238742
[TBL] [Abstract][Full Text] [Related]
18. Validating Well-Functioning Hepatic Organoids for Toxicity Evaluation.
Choi SY; Kim TH; Kim MJ; Mun SJ; Kim TS; Jung KK; Oh IU; Oh JH; Son MJ; Lee JH
Toxics; 2024 May; 12(5):. PubMed ID: 38787150
[TBL] [Abstract][Full Text] [Related]
19. Biomaterials for intestinal organoid technology and personalized disease modeling.
Hirota A; AlMusawi S; Nateri AS; Ordóñez-Morán P; Imajo M
Acta Biomater; 2021 Sep; 132():272-287. PubMed ID: 34023456
[TBL] [Abstract][Full Text] [Related]
20. Guidelines for Manufacturing and Application of Organoids: Brain.
Kwak T; Park SH; Lee S; Shin Y; Yoon KJ; Cho SW; Park JC; Yang SH; Cho H; Im HI; Ahn SJ; Sun W; Yang JH
Int J Stem Cells; 2024 May; 17(2):158-181. PubMed ID: 38777830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
